Association Between a Body Shape Index and Epilepsy Among US Adults: Potential Indirect Pathway Through Depressive Symptoms

BACKGROUND: Epilepsy is a common and disabling brain disorder. Whether a body shape index (ABSI) is associated with epilepsy, and whether depressive symptoms may partly account for this association, remain unclear. METHODS: We analyzed 13,066 participants from the National Health and Nutrition Examination Survey 2013-2018. ABSI was calculated from waist circumference, weight, and height. Epilepsy was identified using prescription medication reason code G40 within the past 30 days. Depressive symptoms were assessed using Patient Health Questionnaire 9. Multivariate logistic regression was used to evaluate associations among ABSI, depressive symptoms, and epilepsy. Restricted cubic splines (RCSs) were applied to examine potential nonlinearity. An exploratory mediation analysis was performed to examine whether depressive symptoms may partly account for the observed association between ABSI and epilepsy. RESULTS: In the multivariate logistic regression analyses, higher ABSI was significantly associated with increased odds of both epilepsy (odds ratio [OR], 1.39; 95% confidence interval [CI], 1.12-1.71) and depressive symptoms (OR, 1.16; 95% CI, 1.08-1.24). Additionally, a positive association was also identified between depressive symptoms and epilepsy (OR, 2.28; 95% CI, 1.41-3.69). RCS analysis revealed that the associations between ABSI and both epilepsy and depressive symptoms were linear (both p for nonlinearity > 0.05). The exploratory mediation analysis indicated that depressive symptoms may partly account for the association between ABSI and epilepsy, accounting for 10.8% of the overall association. CONCLUSIONS: Higher ABSI was associated with a higher prevalence of epilepsy, and depressive symptoms may partly account for this relationship. These findings highlight the potential importance of integrating body composition and mental health perspectives in epilepsy epidemiology and may inform future prospective studies on modifiable metabolic and psychological factors.

Authors

Institutions

Publication Details

Journal
Brain and Behavior
Published
2026-07-28
DOI
https://doi.org/10.1002/brb3.71625
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association Between a Body Shape Index and Epilepsy Among US Adults: Potential Indirect Pathway Through Depressive Symptoms

Shaokun Yang, Jinsong You, Xiujuan Mi, Hongbin Tang et al.
Brain and Behavior
Epilepsy research and treatment
article

Association Between a Body Shape Index and Epilepsy Among US Adults: Potential Indirect Pathway Through Depressive Symptoms

Shaokun Yang, Jinsong You, Xiujuan Mi, Hongbin Tang, Jun Tang, Can Wan, Qiaoduan Feng
article en

Abstract

BACKGROUND: Epilepsy is a common and disabling brain disorder. Whether a body shape index (ABSI) is associated with epilepsy, and whether depressive symptoms may partly account for this association, remain unclear. METHODS: We analyzed 13,066 participants from the National Health and Nutrition Examination Survey 2013-2018. ABSI was calculated from waist circumference, weight, and height. Epilepsy was identified using prescription medication reason code G40 within the past 30 days. Depressive symptoms were assessed using Patient Health Questionnaire 9. Multivariate logistic regression was used to evaluate associations among ABSI, depressive symptoms, and epilepsy. Restricted cubic splines (RCSs) were applied to examine potential nonlinearity. An exploratory mediation analysis was performed to examine whether depressive symptoms may partly account for the observed association between ABSI and epilepsy. RESULTS: In the multivariate logistic regression analyses, higher ABSI was significantly associated with increased odds of both epilepsy (odds ratio [OR], 1.39; 95% confidence interval [CI], 1.12-1.71) and depressive symptoms (OR, 1.16; 95% CI, 1.08-1.24). Additionally, a positive association was also identified between depressive symptoms and epilepsy (OR, 2.28; 95% CI, 1.41-3.69). RCS analysis revealed that the associations between ABSI and both epilepsy and depressive symptoms were linear (both p for nonlinearity > 0.05). The exploratory mediation analysis indicated that depressive symptoms may partly account for the association between ABSI and epilepsy, accounting for 10.8% of the overall association. CONCLUSIONS: Higher ABSI was associated with a higher prevalence of epilepsy, and depressive symptoms may partly account for this relationship. These findings highlight the potential importance of integrating body composition and mental health perspectives in epilepsy epidemiology and may inform future prospective studies on modifiable metabolic and psychological factors.

Brain and BehaviorVol. 16(8)
Guangzhou University of Chinese Medicine (CN), West China Medical Center of Sichuan University (CN), First People's Hospital of Chongqing (CN)
Zero hunger
Openalex Percentile: Top 8%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.